ALTEOGEN Inc. (KOSDAQ:196170)
South Korea · Delayed Price · Currency is KRW 269,500
-7,000 (-2.53%)
Jul 20, 2026, 3:30 PM KST
ALTEOGEN Market Cap
ALTEOGEN has a market cap or net worth of 14.44 trillion as of July 20, 2026. Its market cap has decreased by -44.88% in one year.
Market Cap
14.44T
Enterprise Value
14.10T
Revenue
203.76B
Ranking
n/a
PE Ratio
137.49
Stock Price
269,500.00
ChartMarket Cap Chart
Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 14.44T, an increase of 11,933.72%. That is a compound annual growth rate of 51.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 14.44T | -39.95% |
| Dec 30, 2025 | 24.04T | 45.74% |
| Dec 30, 2024 | 16.49T | 221.05% |
| Dec 28, 2023 | 5.14T | 160.78% |
| Dec 29, 2022 | 1.97T | -38.41% |
| Dec 30, 2021 | 3.20T | -36.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 64.62T |
| Celltrion | 40.32T |
| Samsung Epis Holdings | 9.85T |
| SK Biopharmaceuticals | 6.22T |
| Kolon TissueGene | 5.28T |
| HLB Co., Ltd. | 4.69T |
| LigaChem Biosciences | 3.82T |
| D&D Pharmatech | 3.15T |